Evidence map›Paper›PMID 42900563›Full record

ReviewJournal of applied clinical medical physics2026

Vision and implementation for the first U.S. carbon ion therapy center part II: Design philosophy and clinical implementation.

Xiaoying Liang, Chris J Beltran

Abstract readReview
In one paragraph

Review in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaoying LiangDepartment of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.ORCID https://orcid.org/0000-0002-6688-1045
Chris J BeltranDepartment of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The anticipated clinical demand for carbon ion radiotherapy (CIRT) in the United States is expected to include a substantial proportion of clinically complex disease sites that require accurate, highly conformal, and adaptive treatment. These clinical needs, together with the unique physical and biological characteristics of carbon ion beams, form the foundation of the design philosophy for the Mayo Clinic Florida (MCF) CIRT program. The program remains under active development, with clinical deployment planned for 2028. Building upon the clinical rationale and anticipated U.S. patient population discussed in Part I of this two-part review, this Vision Article describes how MCF intends to develop an integrated CIRT treatment system. The program is guided by two overarching principles: fast, accurate, and safe beam delivery and accurate treatment planning and treatment delivery, supported by an integrated patient-specific quality assurance framework. Key elements include high-dose-rate dose-driven continuous scanning with advanced beam monitoring and irradiation control, delivery-aware treatment planning, the Monte Carlo-based BioPhys computational platform integrating physical and biological dose modeling, a hierarchical adaptive workflow, and patient-specific quality assurance spanning pretreatment, on-treatment, and post-treatment verification. This framework provides a technical roadmap for the integrated clinical implementation of CIRT at MCF.

Indexed as

Heavy Ion RadiotherapyNeoplasmsQuality Assurance, Health CareRadiotherapy Planning, Computer-AssistedHumansMonte Carlo MethodRadiotherapy DosageUnited States

Identifiers

PMID42900563
PMCPMC13682618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.